[11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis

Summary

This open-label positron emission tomography (PET) study is designed to determine the effect of ABT-555 on translocator protein expression level in participants with relapsing forms of multiple sclerosis.

Timeline

Start

2015-10

Primary completion

2015-12

Completion

2015-12

Outcome

Outcome not reported

Stopped: “Company decision”

Drugs

Indications